Bruno Costa Martins, Andressa Abnader Machado, Rodrigo Corsato Scomparin, Gustavo Andrade Paulo, Adriana Safatle-Ribeiro, Sebastian Naschold Geiger, Luciano Lenz, Marcelo Simas Lima, Caterina Pennacchi, Ulysses Ribeiro, Alan N Barkun, Fauze Maluf-Filho
Background and study aims Upper gastrointestinal bleeding (UGIB) from malignancy is associated with high rebleeding and mortality rates. Recently, TC-325 powder has shown promising results in the treatment of UGIB, including malignant bleeding. The aim of this study was to compare the efficacy of TC-325 versus best clinical management. Patients and methods From August 2016 to February 2020, all patients with evidence of UGIB from malignancy were randomized to receive TC-325 therapy or control group, in which endoscopic treatment was not mandatory...
October 2022: Endoscopy International Open